External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Cardiovascular ESC 2024
Roche and Genentech at

ESC 2024

August 30 - September 02
London, United Kingdom / Virtual (Hybrid)
escardio.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
01:30 PM
Duration 6mins London, United Kingdom
Subgroup Results from KARDIA-2: Impact of Demographic and Baseline Disease Characteristics on Zilebesiran Response in Patients with Hypertension Uncontrolled by a Standard Oral Antihypertensive
Manish Saxena, Ahmad Aswad, Jolita Badariene, Asad Karim, Ying Tung Sia, Daniel Stiglitz, Nune Makarova, Andrea Havasi, Dion Zappe, George Bakris
Cardiovascular | Hypertension

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.